NorthStar Medical Radioisotopes
Manufacturing · Wisconsin, United States · 257 Employees
View Company Info for Free
About
Headquarters
1800 Gateway Blvd, Beloit, Wisconsin, 53511, Un...Phone Number
(608) 313-8000Website
www.northstarnm.comRevenue
$64.4 MillionIndustry
Most Recent Scoops
Highlights
$117M
Total Funding Amount
$100M
Most Recent Funding Amount
3
Number of Funding Rounds
Who is NorthStar Medical Radioisotopes
NorthStar Medical Radioisotopes Org Chart
Is NorthStar Medical Radioisotopes your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if NorthStar Medical Radioisotopes is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on NorthStar Medical Radioisotopes recently announced quarterly report
Check if NorthStar Medical Radioisotopes has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once NorthStar Medical Radioisotopes has new funding data
Congratulate Masked Content for being promoted to Masked Content at NorthStar Medical Radioisotopes
Product Launch: Get notified when NorthStar Medical Radioisotopes launches new products
NorthStar Medical Radioisotopes, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if NorthStar Medical Radioisotopes had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined NorthStar Medical Radioisotopes as Masked Content
Find 2 more new buyers
Compare Similar Companies to NorthStar Medical Radioisotopes
Compare insights from companies similar to NorthStar Medical Radioisotopes, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NorthStar Medical Radiois...
NorthStar Medical Radioisotopes financials insights
Gather financial insights about NorthStar Medical Radioisotopes, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
NorthStar Medical Radioisotopes Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
NorthStar Medical Radioisotopes Tech Stack
A closer look at the technologies used by NorthStar Medical Radioisotopes
Most Recent Scoops
NorthStar Medical Radioisotopes News & Media
NorthStar Medical Radioisotopes and YAP Therapeutics Enter Into Collaboration Agreement for the Development and Production of Radiopharmaceutical Products
BELOIT, Wis. & LAGUNA HILLS, Calif.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes and YAP Therapeutics Enter into Collaboration Agreement for Development and Production of Radiopharmaceutical ProductsAriceum Therapeutics and NorthStar Medical Radioisotopes Announce Supply Agreement for Therapeutic Radioisotope Actinium-225
NorthStar will supply non-carrier added Actinium-225, a radionuclide, for use with Ariceum's first-in-class radiopharmaceutical drug, satoreotide BERLIN and BELOIT, Wis., Dec. 11, 2024 /PRNewswire/ -- Ariceum Therapeutics, a private biotech company developing radiopharmaceutical products...NorthStar Medical Radioisotopes and PDRadiopharma Announce Research and Development Agreement, Master Isotope Supply Agreement for Ac-225 and Contract Manufacturing and Master Services Agreement
BELOIT, Wis. & KAWASAKI, Japan--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC, and PeptiDream Inc. (President: Patrick C. Reid, Tokyo: 4587) today announced that PeptiDream’s wholly owned subsidiary PDRadiopharma Inc. (President: Masato Murakami) has entered into a strategic collaboration with NorthStar, a global innovator in the development, production, and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging. PDRadiopharma is the leading radiNorthStar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225)
BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC today announced the signing of a strategic Master Supply Agreement with Cellectar Biosciences, Inc. (NASDAQ: CLRB) under which Cellectar will acquire and integrate NorthStar’s n.c.a. Ac-225 into Cellectar’s proprietary Phospholipid Ethers (PLE) delivery platform to expand the platform’s capability to produce a diverse range of radiotherapeutic molecules. NorthStar is a global innovator in the development, production, and commer
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding NorthStar Medical Radioisotopes
NorthStar Medical Radioisotopes is a privately held company that develops nuclear medicine technology to provide sustainable and safe radioisotope supply solutions. The company was founded in 2006 and is headquartered in Beloit, Wisconsin.... Read More